Could we design the RCT as a non-inferiority trial at this situation? [Design Issues]

posted by dennis001 – Hong Kong, 2022-07-27 07:21 (1023 d 23:57 ago) – Posting: # 23181
Views: 3,854

Dear ElMaestro
Thanks!

❝ Clearly a case for an NI trial one way or another.


Thank you for your comment that helped to assuage my doubts.

❝ Clearly a case for a scientific advice where you need the authority's nod for margin and design before you kick off.


Ok. we will discuss with them.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
143 visitors (0 registered, 143 guests [including 11 identified bots]).
Forum time: 07:19 CEST (Europe/Vienna)

A statistical analysis, properly conducted, is a delicate dissection of
uncertainties, a surgery of suppositions.    Micheal J. Moroney

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5